Multiple sclerosis v2

Download CSV Download definition
Coding system
CTV3 (Read V3)
Coding system release
unknown
Organisation
OpenSAFELY
Codelist ID
opensafely/multiple-sclerosis-v2
Version ID
063627df
Versions
  • 063627df

Description

Codelist for multiple sclerosis including Y codes not mapped previously, Balo disease, Schilder's disease Also includes clinically isolated syndrome and optic neuromyelitis

Methodology

Codelist designed to identify people who may not have a discrete episode of acute transverse myelitis recorded, due to a diagnosis of MS

This list includes all codes in https://www.opencodelists.org/codelist/opensafely/multiple-sclerosis/2020-05-12/ It additionally includes: - Y codes (Y1015 Multiple Sclerosis; Y1f23 Multiple sclerosis monitoring invitation) - Balo and Schilder's disease (X005l Balo concentric sclerosis; F211. Schilder's disease or Balo's concentric sclerosis)

This codelist also includes two related conditions which could be removed for a codelist solely of MS: - Clinically isolated syndrome, on the basis that a person with clinically isolated syndrome who experiences acute transverse myelitis may be diagnosed directly with MS rather than coded as acute transverse myelitis - Optic neuromyelitis, as this condition also includes recurrent episodes of acute transverse myelitis

The codelist was developed with advice from Arina Tamborska, University of Liverpool

References

Signed off by

  • Helen McDonald, (Aug. 26, 2021)

Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.

We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.

code term
F20.. Multiple sclerosis
F200. Multiple sclerosis of the brainstem
F201. Multiple sclerosis of the spinal cord
F202. Generalised multiple sclerosis
F203. Exacerbation of multiple sclerosis
F20z. Multiple sclerosis NOS
F210. Optic neuromyelitis
F211. (Schilder's disease) or (Balo's concentric sclerosis)
X005c Acute relapsing multiple sclerosis
X005d Chronic progressive multiple sclerosis
X005e Remittent-progressive multiple sclerosis
X005l Balo concentric sclerosis
XaKA8 Specialised services for pts with multiple sclerosis ESA
XaKvm Multiple sclerosis review
XaKvn Multiple sclerosis multidisciplinary review
XaKzg Multiple sclerosis care plan agreed
XaOzZ Benign multiple sclerosis
XaP0X Malignant multiple sclerosis
XaP0r Primary progressive multiple sclerosis
XaP1B Relapsing and remitting multiple sclerosis
XaP1V Secondary progressive multiple sclerosis
XaPSY Management of multiple sclerosis in onset phase
XaPSZ Management of multiple sclerosis in early disease phase
XaPSa Management of multiple sclerosis in stable disability phase
XaPSb Management of MS in progressive disability phase
XaPSc Management of multiple sclerosis in palliative phase
XaX9A Multiple sclerosis monitoring administration
XaX9F Multiple sclerosis monitoring first letter
XaX9H Multiple sclerosis monitoring second letter
XaX9J Multiple sclerosis monitoring telephone invitation
XaX9L Multiple sclerosis monitoring third letter
XaXsg Referral to community multiple sclerosis team
XaYP3 Clinically isolated syndrome
Y1015 Multiple Sclerosis
Y10b7 Multiple Sclerosis
Y1f23 Multiple sclerosis monitoring invitation

Codes not in the full codelist are in faint grey.

This page shows the search terms that were used to build the codelist. Concepts that match the search terms, but which were excluded, are in faint grey.

balo concentric

Included 2 out of 2 matching concepts.

Show matching concepts
  • (Schilder's disease) or (Balo's concentric sclerosis) (F211.)
  • Balo concentric sclerosis (X005l)

clinically isolated

Included 1 out of 1 matching concepts.

Show matching concepts
  • Clinically isolated syndrome (XaYP3)

multiple sclerosis

Included 32 out of 51 matching concepts.

Show matching concepts
  • AUBAGIO 14mg tablets (dA41.)
  • Acute relapsing multiple sclerosis (X005c)
  • Benign multiple sclerosis (XaOzZ)
  • CANNABINOIDS (dA2..)
  • Chronic progressive multiple sclerosis (X005d)
  • DIMETHYL FUMARATE (dA5..)
  • DIMETHYL FUMARATE 120mg gastro-resistant capsules (dA52.)
  • DIMETHYL FUMARATE 240mg gastro-resistant capsules (dA54.)
  • DRONABINOL+CANNABIDIOL 2.7mg/2.5mg oromucosal spray (dA21.)
  • Exacerbation of multiple sclerosis (F203.)
  • FAMPRIDINE (dA3..)
  • FAMPRIDINE 10mg m/r tablets (dA32.)
  • FAMPYRA 10mg m/r tablets (dA31.)
  • FH: Multiple sclerosis (1292.)
  • Generalised multiple sclerosis (F202.)
  • Kurtzke multiple sclerosis rating scale (XM0eo)
  • Malignant multiple sclerosis (XaP0X)
  • Management of MS in progressive disability phase (XaPSb)
  • Management of multiple sclerosis in early disease phase (XaPSZ)
  • Management of multiple sclerosis in onset phase (XaPSY)
  • Management of multiple sclerosis in palliative phase (XaPSc)
  • Management of multiple sclerosis in stable disability phase (XaPSa)
  • Multiple Sclerosis (Y10b7)
  • Multiple Sclerosis (Y1015)
  • Multiple sclerosis (F20..)
  • Multiple sclerosis NOS (F20z.)
  • Multiple sclerosis care plan agreed (XaKzg)
  • Multiple sclerosis monitoring administration (XaX9A)
  • Multiple sclerosis monitoring first letter (XaX9F)
  • Multiple sclerosis monitoring invitation (Y1f23)
  • Multiple sclerosis monitoring second letter (XaX9H)
  • Multiple sclerosis monitoring telephone invitation (XaX9J)
  • Multiple sclerosis monitoring third letter (XaX9L)
  • Multiple sclerosis multidisciplinary review (XaKvn)
  • Multiple sclerosis of the brainstem (F200.)
  • Multiple sclerosis of the spinal cord (F201.)
  • Multiple sclerosis review (XaKvm)
  • Multiple sclerosis review declined (XaQwl)
  • Other drugs used for the treatment of multiple sclerosis (dA...)
  • Primary progressive multiple sclerosis (XaP0r)
  • Referral to community multiple sclerosis team (XaXsg)
  • Relapsing and remitting multiple sclerosis (XaP1B)
  • Remittent-progressive multiple sclerosis (X005e)
  • SATIVEX oromucosal spray (dA22.)
  • Secondary progressive multiple sclerosis (XaP1V)
  • Specialised services for pts with multiple sclerosis ESA (XaKA8)
  • Suspected multiple sclerosis (XaaJn)
  • TECFIDERA 120mg gastro-resistant capsules (dA51.)
  • TECFIDERA 240mg gastro-resistant capsules (dA53.)
  • TERIFLUNOMIDE (dA4..)
  • TERIFLUNOMIDE 14mg tablets (dA42.)

optic neuromyelitis

Included 1 out of 1 matching concepts.

Show matching concepts
  • Optic neuromyelitis (F210.)